Dublin, Sept. 19, 2023 (GLOBE NEWSWIRE) -- The "Spirodiclofen: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Spirodiclofen Market to Reach $240.2 Million by 2030
The global market for Spirodiclofen estimated at US$164.1 Million in the year 2022, is projected to reach a revised size of US$240.2 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2022-2030.
The U.S. Market is Estimated at $44 Million, While China is Forecast to Grow at 7.3% CAGR
The Spirodiclofen market in the U.S. is estimated at US$44 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$52.3 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.
Market Scope
This data provides valuable insights into the Spirodiclofen global market. It includes forecasts for Spirodiclofen market values in US dollars across different regions and countries from 2022 to 2030, offering a glimpse into expected market growth and distribution.
Additionally, historical market data from 2014 to 2021 is presented, allowing for an analysis of past trends and market fluctuations.
Furthermore, a comparison of Spirodiclofen market share across key geographic regions in 2014, 2022, and 2030 highlights evolving market dynamics and shifts in regional market dominance.
Lastly, the annual sales of Spirodiclofen in US dollars for the years 2014 through 2030 are summarized, providing a comprehensive overview of market performance over this 16-year period, including trends, growth patterns, and potential opportunities or challenges within the Spirodiclofen market.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Market Overview
- Influencer Market Insights
- World Market Trajectories
- Spirodiclofen - Global Key Competitors Percentage Market Share in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Select Competitors (Total 46 Featured)
- Bayer CropScience
- E.I. du Pont de Nemours and Company
- Hangzhou Tianlong Biotechnology Company
- Hebei Brilliant Chemical Co LTD
- Shandong Hailir Chemical Ltd
- Shijiazhuang Xingbai Bioengineering Ltd
- Zhaoyuan Sanlian Chemical Group Company
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 196 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $164.1 Million |
| Forecasted Market Value (USD) by 2030 | $240.2 Million |
| Compound Annual Growth Rate | 4.9% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/ixzt6m
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
